• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人α-凝血酶与水蛭素和对脒基苯丙酮酸复合物在1.6埃分辨率下的晶体结构。

Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution.

作者信息

Chen Z, Li Y, Mulichak A M, Lewis S D, Shafer J A

机构信息

Department of Biological Chemistry, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

出版信息

Arch Biochem Biophys. 1995 Sep 10;322(1):198-203. doi: 10.1006/abbi.1995.1452.

DOI:10.1006/abbi.1995.1452
PMID:7574675
Abstract

Crystals of human alpha-thrombin complexed with hirugen and the alpha-keto acid thrombin inhibitor APPA (p-amidinophenylpyruvate) that diffract to 1.6 A resolution were obtained by soaking an alpha-thrombin-hirugen crystal in a solution of APPA. The crystal structure was determined using the difference Fourier method and refined to an R factor of 18.7% at 1.6 A resolution. This structure is the highest resolution structure of the thrombin molecule that is currently available. With the exception of the region near Arg77A-Asn78, the structures of the thrombin and hirugen molecules in the ternary complex are similar to those reported for the thrombin-hirugen binary complex. As previously determined for the APPA-trypsin complex, the carbonyl carbon atom of APPA forms a covalent bond with O gamma of Ser195 of thrombin to yield a "transition-state" analog of the tetrahedral intermediate. Comparison of the specificity pocket of the APPA complexes of thrombin and trypsin reveals differences in hydrogen bonding and shows for the first time that the S1 site of thrombin is larger than that of trypsin and as a result thrombin may be able to accommodate a bulkier P1 group than trypsin.

摘要

通过将α-凝血酶-水蛭素晶体浸泡在APPA(对脒基苯丙酮酸)溶液中,获得了与水蛭素和α-酮酸凝血酶抑制剂APPA复合的人α-凝血酶晶体,其衍射分辨率达到1.6 Å。使用差值傅里叶方法确定了晶体结构,并在1.6 Å分辨率下精修至R因子为18.7%。该结构是目前可用的凝血酶分子的最高分辨率结构。除了靠近Arg77A-Asn78的区域外,三元复合物中凝血酶和水蛭素分子的结构与报道的凝血酶-水蛭素二元复合物的结构相似。如先前对APPA-胰蛋白酶复合物所确定的,APPA的羰基碳原子与凝血酶的Ser195的Oγ形成共价键,从而产生四面体中间体的“过渡态”类似物。凝血酶和胰蛋白酶的APPA复合物的特异性口袋的比较揭示了氢键的差异,并首次表明凝血酶的S1位点比胰蛋白酶的大,因此凝血酶可能比胰蛋白酶能够容纳更大的P1基团。

相似文献

1
Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution.人α-凝血酶与水蛭素和对脒基苯丙酮酸复合物在1.6埃分辨率下的晶体结构。
Arch Biochem Biophys. 1995 Sep 10;322(1):198-203. doi: 10.1006/abbi.1995.1452.
2
The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.凝血酶原2、水蛭素和PPACK-凝血酶的同构结构:激活及外位点与凝血酶结合过程中的变化
Protein Sci. 1994 Dec;3(12):2254-71. doi: 10.1002/pro.5560031211.
3
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.α-凝血酶的水蛭素和水蛭素-1复合物的结构
J Mol Biol. 1991 Oct 20;221(4):1379-93.
4
Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.活性位点滴定剂Nα-(N,N-二甲基氨基甲酰基)-α-氮杂赖氨酸对硝基苯酯对人α-凝血酶的抑制作用:一项比较动力学和X射线晶体学研究。
J Mol Biol. 1996 May 24;258(5):851-9. doi: 10.1006/jmbi.1996.0292.
5
Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.与在P1位具有环己基部分的选择性非亲电抑制剂复合的凝血酶的结构。
Acta Crystallogr D Biol Crystallogr. 2000 Mar;56(Pt 3):294-303. doi: 10.1107/s0907444900000068.
6
Crystallographic structure of human gamma-thrombin.人γ-凝血酶的晶体结构
J Biol Chem. 1994 Sep 2;269(35):22000-6.
7
Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.人α-凝血酶和牛β-胰蛋白酶的环赛托酰胺A复合物结构比较。
Protein Sci. 1996 May;5(5):825-35. doi: 10.1002/pro.5560050504.
8
Structure of the Ser195Ala mutant of human alpha--thrombin complexed with fibrinopeptide A(7--16): evidence for residual catalytic activity.与纤维蛋白肽A(7-16)复合的人α-凝血酶Ser195Ala突变体的结构:残余催化活性的证据
Acta Crystallogr D Biol Crystallogr. 2000 Apr;56(Pt 4):406-10. doi: 10.1107/s0907444900001487.
9
Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors.水蛭素3-凝血酶复合物的结构以及底物和抑制剂S'亚位点的性质。
Biochemistry. 1992 Dec 1;31(47):11689-97. doi: 10.1021/bi00162a004.
10
The determination of protonation states in proteins.蛋白质中质子化状态的测定。
Acta Crystallogr D Biol Crystallogr. 2007 Aug;63(Pt 8):906-22. doi: 10.1107/S0907444907029976. Epub 2007 Jul 17.

引用本文的文献

1
Proton Bridging in Catalysis by and Inhibition of Serine Proteases of the Blood Cascade System.血液级联系统丝氨酸蛋白酶催化作用及抑制过程中的质子桥连
Life (Basel). 2021 Apr 27;11(5):396. doi: 10.3390/life11050396.
2
Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?不考虑现有结构数据,仅将分子对接得分最高的构象作为最佳解决方案是否可靠?
Molecules. 2018 Apr 28;23(5):1038. doi: 10.3390/molecules23051038.
3
Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors.
基于 D-Phe-Pro-D-Arg 的直接凝血酶抑制剂的合理设计与表征。
PLoS One. 2012;7(3):e34354. doi: 10.1371/journal.pone.0034354. Epub 2012 Mar 23.
4
Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model.基于连续静电模型线性相互作用能的苯甲脒类凝血酶抑制剂的筛选。
J Comput Aided Mol Des. 2010 Feb;24(2):117-29. doi: 10.1007/s10822-010-9320-1. Epub 2010 Feb 11.
5
Protein tyrosine-O-sulfation in the retina.视网膜中的蛋白酪氨酸-O-硫酸化。
Exp Eye Res. 2009 Oct;89(4):559-67. doi: 10.1016/j.exer.2009.05.010. Epub 2009 Jun 11.
6
Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin.与凝血酶复合的生物合成磺基水蛭素的晶体结构。
J Am Chem Soc. 2007 Sep 5;129(35):10648-9. doi: 10.1021/ja0735002. Epub 2007 Aug 9.
7
A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP.药效团识别程序的比较:Catalyst、DISCO和GASP。
J Comput Aided Mol Des. 2002 Aug-Sep;16(8-9):653-81. doi: 10.1023/a:1021954728347.
8
Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.抑制剂结合可诱导丙型肝炎病毒NS3蛋白丝氨酸蛋白酶结构域的活性位点稳定。
EMBO J. 2000 Mar 15;19(6):1195-206. doi: 10.1093/emboj/19.6.1195.
9
Structural basis for chemical inhibition of human blood coagulation factor Xa.人凝血因子Xa化学抑制的结构基础。
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6630-5. doi: 10.1073/pnas.95.12.6630.